ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.040
+0.020 (1.96%)
Oct 2, 2026, 10:30 AM EDT - Market open
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $26.96 million as of October 2, 2026. Its market cap has decreased by -62.35% in one year.
Market Cap
26.96M
Enterprise Value
29.75M
1-Year Change
-62.35%
Ranking
Category
Stock Price
$1.04
ChartMarket Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $26.96M, a decrease of -66.09%. That is a compound annual growth rate of -18.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 27.20M | -47.49% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 29.13M |
| Context Therapeutics | 28.89M |
| aTyr Pharma | 28.85M |
| IGC Pharma | 27.91M |
| Quantum BioPharma | 27.70M |
| Evaxion | 26.52M |
| Kyntra Bio | 26.32M |
| TransCode Therapeutics | 26.16M |